康华生物(300841.SZ)：控股股东变更为万可欣生物

Core Viewpoint - Kanghua Biotech has completed the transfer of shares to Shanghai Wankexin Biotechnology Partnership, resulting in a change of controlling shareholder to Wankexin Biotech, with no actual controller remaining in the company [1] Group 1 - Wang Zhentao and his concerted parties, including Aokang Group and Jinan Kangyue Qiming Investment Partnership, have successfully transferred shares of Chengdu Kanghua Biotech Co., Ltd. to Wankexin Biotech [1] - The share transfer has been officially registered with China Securities Depository and Clearing Corporation Limited [1] - Following the completion of the share transfer, the controlling shareholder of the company has changed to Wankexin Biotech, indicating a shift in ownership structure [1]